Immatics (IMTX) Total Current Liabilities (2019 - 2025)

Immatics' (IMTX) quarterly Total Current Liabilities came in at $50.1 million in Q4 2025, down 31.08% year-on-year from $72.7 million in Q4 2024, and down 31.21% quarter-over-quarter from $72.8 million in Q3 2025.

Immatics (IMTX) Total Current Liabilities (2019 - 2025) Analysis & Trends

Immatics has disclosed Total Current Liabilities across 7 years of filings, most recently posting $50.1 million for Q4 2025.

  • Total Current Liabilities for Q4 2025 came in at $50.1 million, down 31.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $50.1 million (down 31.08% YoY), and the FY2025 annual result was $48.6 million, down 33.11% from the prior year.
  • Total Current Liabilities came in at $50.1 million for Q4 2025 at Immatics, down from $72.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $168.4 million in Q4 2023 to a low of $50.1 million in Q4 2025.
  • The 5-year median for Total Current Liabilities is $111.0 million (2021), against an average of $111.9 million.
  • Across the five-year window, Total Current Liabilities soared 55.09% in 2023 and tumbled 63.78% in 2025, its largest moves.
  • Immatics' Total Current Liabilities stood at $108.8 million in 2021, then dropped by 0.22% to $108.6 million in 2022, then jumped by 55.09% to $168.4 million in 2023, then plunged by 56.87% to $72.7 million in 2024, then tumbled by 31.08% to $50.1 million in 2025.
  • The last three Total Current Liabilities figures came in at $50.1 million (Q4 2025), $72.8 million (Q3 2025), and $64.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Immatics 14.67 Bn 14.67 Bn - 50.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 50.07 Mn
Sep 30, 2025 72.78 Mn
Jun 30, 2025 64.80 Mn
Mar 31, 2025 58.66 Mn
Dec 31, 2024 72.65 Mn
Sep 30, 2024 141.57 Mn
Jun 30, 2024 161.04 Mn
Mar 31, 2024 161.98 Mn
Dec 31, 2023 168.44 Mn
Sep 30, 2023 131.88 Mn
Jun 30, 2023 135.36 Mn
Mar 31, 2023 107.96 Mn
Dec 31, 2022 108.61 Mn
Sep 30, 2022 125.15 Mn
Jun 30, 2022 121.64 Mn
Mar 31, 2022 103.09 Mn
Dec 31, 2021 108.85 Mn
Sep 30, 2021 126.33 Mn
Jun 30, 2021 113.12 Mn
Mar 31, 2021 103.84 Mn